Skip to main content
Erschienen in: The International Journal of Cardiovascular Imaging 5/2009

01.06.2009 | Original Paper

First-pass myocardial perfusion abnormalities in Churg-Strauss Syndrome with cardiac involvement

verfasst von: Andreas Hansch, Alexander Pfeil, Reinhard Rzanny, Thomas Neumann, Werner A. Kaiser

Erschienen in: The International Journal of Cardiovascular Imaging | Ausgabe 5/2009

Einloggen, um Zugang zu erhalten

Abstract

This study sought to evaluate whether representative abnormalities can be identified by first-pass perfusion (FPP) studies in patients with Churg-Strauss Syndrome (CSS), a rare disease characterized by small-vessel vasculitis. Seven patients with CSS (3 men, 4 women; mean age 55 ± 7 years) were investigated. Echocardiography was performed in all patients and coronary angiography in 5 patients. Magnetic resonance imaging (MRI) was performed with a 1.5 T whole body scanner in all patients. Functional cardiac imaging, T2-weighted turbo inversion recovery magnitude images, and T2-weighted turbo spin echo sequences with fat saturation were also performed. Cardiac viability was assessed by myocardial FPP imaging at rest and by delayed contrast enhancement (DCE) images. The FPP was abnormal in 5 of the 7 CSS patients. The abnormality was localized in the subendocardium of the left ventricle, particularly in areas of myocardial inflammatory edema. All patients showed subendocardial DCE abnormalities in the left ventricle, and 2 patients also in the right ventricle. The localization was typically subendocardial. This study describes a myocardial FPP deficit at rest in patients with CSS. The deficit is localized in areas of inflammatory myocardial edema. This diagnostic technique and image evaluation is simple, quick, and harmless. Due to the rarity of CSS, further studies are necessary to evaluate the impact of these findings.
Literatur
2.
Zurück zum Zitat Manning WJ, Atkinson DJ, Grossman W, Paulin S, Edelman RR (1991) First-pass nuclear magnetic resonance imaging studies using gadolinium-DTPA in patients with coronary artery disease. J Am Coll Cardiol 18:959–965PubMedCrossRef Manning WJ, Atkinson DJ, Grossman W, Paulin S, Edelman RR (1991) First-pass nuclear magnetic resonance imaging studies using gadolinium-DTPA in patients with coronary artery disease. J Am Coll Cardiol 18:959–965PubMedCrossRef
3.
Zurück zum Zitat Barmeyer AA, Stork A, Muellerleile K, Schofer AK, Tiburtius C, Koester R et al (2008) Comparison of quantitative coronary angiography and first-pass perfusion magnetic resonance imaging for the detection of an impaired coronary perfusion in nonsevere coronary stenosis. J Magn Reson Imaging 27:1005–1011. doi:10.1002/jmri.21341 PubMedCrossRef Barmeyer AA, Stork A, Muellerleile K, Schofer AK, Tiburtius C, Koester R et al (2008) Comparison of quantitative coronary angiography and first-pass perfusion magnetic resonance imaging for the detection of an impaired coronary perfusion in nonsevere coronary stenosis. J Magn Reson Imaging 27:1005–1011. doi:10.​1002/​jmri.​21341 PubMedCrossRef
4.
Zurück zum Zitat Canyigit M, Turkbey B, Hazirolan T, Peynircioglu B, Aytemir K (2008) Magnetic resonance imaging first-pass myocardial perfusion in evaluation of hemodynamic effects of myocardial bridging. J Comput Assist Tomogr 32:274–275. doi:10.1097/RCT.0b013e318074c5b7 PubMedCrossRef Canyigit M, Turkbey B, Hazirolan T, Peynircioglu B, Aytemir K (2008) Magnetic resonance imaging first-pass myocardial perfusion in evaluation of hemodynamic effects of myocardial bridging. J Comput Assist Tomogr 32:274–275. doi:10.​1097/​RCT.​0b013e318074c5b7​ PubMedCrossRef
8.
Zurück zum Zitat Gerber BL, Raman SV, Nayak K, Epstein FH, Ferreira P, Axel L et al (2008) Myocardial first-pass perfusion cardiovascular magnetic resonance: history, theory, and current state of the art. J Cardiovasc Magn Reson 10:18. doi:10.1186/1532-429X-10-18 PubMedCrossRef Gerber BL, Raman SV, Nayak K, Epstein FH, Ferreira P, Axel L et al (2008) Myocardial first-pass perfusion cardiovascular magnetic resonance: history, theory, and current state of the art. J Cardiovasc Magn Reson 10:18. doi:10.​1186/​1532-429X-10-18 PubMedCrossRef
12.
Zurück zum Zitat Schwab J, Zahn R, Bar I (2008) MR tomography presentation of endomyocardial fibrosis as an expression of cardiac involvement in Churg-Strauss syndrome. Rofo 180:55–57PubMed Schwab J, Zahn R, Bar I (2008) MR tomography presentation of endomyocardial fibrosis as an expression of cardiac involvement in Churg-Strauss syndrome. Rofo 180:55–57PubMed
13.
Zurück zum Zitat Baccouche H, Yilmaz A, Alscher D, Klingel K, Val-Bernal JF, Mahrholdt H (2008) Images in cardiovascular medicine. Magnetic resonance assessment and therapy monitoring of cardiac involvement in Churg-Strauss syndrome. Circulation 117:1745–1749. doi:10.1161/CIRCULATIONAHA.107.721738 PubMedCrossRef Baccouche H, Yilmaz A, Alscher D, Klingel K, Val-Bernal JF, Mahrholdt H (2008) Images in cardiovascular medicine. Magnetic resonance assessment and therapy monitoring of cardiac involvement in Churg-Strauss syndrome. Circulation 117:1745–1749. doi:10.​1161/​CIRCULATIONAHA.​107.​721738 PubMedCrossRef
14.
17.
Zurück zum Zitat Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP et al (1990) The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 33:1094–1100PubMed Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP et al (1990) The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 33:1094–1100PubMed
18.
Zurück zum Zitat Laissy JP, Hyafil F, Feldman LJ, Juliard JM, Schouman-Claeys E, Steg PG et al (2005) Differentiating acute myocardial infarction from myocarditis: diagnostic value of early- and delayed-perfusion cardiac MR imaging. Radiology 237:75–82. doi:10.1148/radiol.2371041322 PubMedCrossRef Laissy JP, Hyafil F, Feldman LJ, Juliard JM, Schouman-Claeys E, Steg PG et al (2005) Differentiating acute myocardial infarction from myocarditis: diagnostic value of early- and delayed-perfusion cardiac MR imaging. Radiology 237:75–82. doi:10.​1148/​radiol.​2371041322 PubMedCrossRef
19.
Zurück zum Zitat Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK et al (2002) Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105:539–542. doi:10.1161/hc0402.102975 PubMedCrossRef Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK et al (2002) Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105:539–542. doi:10.​1161/​hc0402.​102975 PubMedCrossRef
20.
Zurück zum Zitat Frustaci A, Gentiloni N, Chimenti C, Natale L, Gasbarrini G, Maseri A (1998) Necrotizing myocardial vasculitis in Churg-Strauss syndrome: clinicohistologic evaluation of steroids and immunosuppressive therapy. Chest 114:1484–1489. doi:10.1378/chest.114.5.1484 PubMedCrossRef Frustaci A, Gentiloni N, Chimenti C, Natale L, Gasbarrini G, Maseri A (1998) Necrotizing myocardial vasculitis in Churg-Strauss syndrome: clinicohistologic evaluation of steroids and immunosuppressive therapy. Chest 114:1484–1489. doi:10.​1378/​chest.​114.​5.​1484 PubMedCrossRef
22.
Zurück zum Zitat Kramer CM, Barkhausen J, Flamm SD, Kim RJ, Nagel E (2008) Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols. J Cardiovasc Magn Reson 10:35. doi:10.1186/1532-429X-10-35 CrossRefPubMed Kramer CM, Barkhausen J, Flamm SD, Kim RJ, Nagel E (2008) Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols. J Cardiovasc Magn Reson 10:35. doi:10.​1186/​1532-429X-10-35 CrossRefPubMed
23.
25.
Zurück zum Zitat Wilke N, Jerosch-Herold M, Wang Y, Huang Y, Christensen BV, Stillman AE et al (1997) Myocardial perfusion reserve: assessment with multisection, quantitative, first-pass MR imaging. Radiology 204:373–384PubMed Wilke N, Jerosch-Herold M, Wang Y, Huang Y, Christensen BV, Stillman AE et al (1997) Myocardial perfusion reserve: assessment with multisection, quantitative, first-pass MR imaging. Radiology 204:373–384PubMed
26.
Zurück zum Zitat De Cobelli F, Pieroni M, Esposito A, Chimenti C, Belloni E, Mellone R et al (2006) Delayed gadolinium-enhanced cardiac magnetic resonance in patients with chronic myocarditis presenting with heart failure or recurrent arrhythmias. J Am Coll Cardiol 47:1649–1654. doi:10.1016/j.jacc.2005.11.067 PubMedCrossRef De Cobelli F, Pieroni M, Esposito A, Chimenti C, Belloni E, Mellone R et al (2006) Delayed gadolinium-enhanced cardiac magnetic resonance in patients with chronic myocarditis presenting with heart failure or recurrent arrhythmias. J Am Coll Cardiol 47:1649–1654. doi:10.​1016/​j.​jacc.​2005.​11.​067 PubMedCrossRef
Metadaten
Titel
First-pass myocardial perfusion abnormalities in Churg-Strauss Syndrome with cardiac involvement
verfasst von
Andreas Hansch
Alexander Pfeil
Reinhard Rzanny
Thomas Neumann
Werner A. Kaiser
Publikationsdatum
01.06.2009
Verlag
Springer Netherlands
Erschienen in
The International Journal of Cardiovascular Imaging / Ausgabe 5/2009
Print ISSN: 1569-5794
Elektronische ISSN: 1875-8312
DOI
https://doi.org/10.1007/s10554-009-9457-y

Weitere Artikel der Ausgabe 5/2009

The International Journal of Cardiovascular Imaging 5/2009 Zur Ausgabe

Case in Point

Lucky adhesion

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.